NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
08/05/2023
Back to search
Official data from USPTO
GEISINGER CANCER INSTITUTE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
GEISINGER CANCER INSTITUTE
ST13
US500000076273651Class
42
Filing
76273651
Registration
2682625
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
33
Latest update
08/05/2023
Trademark type
Word
Nice classes
42
Filing date
06/19/2001
Registration date
02/04/2003
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/05/2023
Last transaction
08/05/2023
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
First use anywhere
12/18/2000
First use in commerce
12/18/2000
Drawing code
1
Owner type
99
Owner location
DANVILLE, PA, US
Examiner
BOAGNI, MARY
Law office
M50
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
G. C. (pessoa física)
G. F. (pessoa física)
Representatives
Bassam N. Ibrahim Buchanan Ingersoll & Rooney, P.C.
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
providing health care services for cancer patients
Publications
History of USPTO decisions and trademark events.
33 publications found
RNL2
REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
08/05/2023
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
08/05/2023
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
08/05/2023
E89R
TEAS SECTION 8 & 9 RECEIVED
01/18/2023
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
02/04/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
10/28/2019
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
10/28/2019
CORV
REVIEW OF CORRESPONDENCE COMPLETE - POWER OF ATTORNEY ENTERED
10/18/2017
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
10/17/2017
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
04/04/2017
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
03/28/2017
NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
05/30/2012
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
05/30/2012
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
05/30/2012
E89R
TEAS SECTION 8 & 9 RECEIVED
05/23/2012
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
06/07/2011
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
06/07/2011
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
05/27/2008
PLGL
ASSIGNED TO PARALEGAL
05/06/2008
E815
TEAS SECTION 8 & 15 RECEIVED
04/18/2008
CFIT
CASE FILE IN TICRS
04/15/2008
R.PR
REGISTERED-PRINCIPAL REGISTER
02/04/2003
PUBO
PUBLISHED FOR OPPOSITION
11/12/2002
NPUB
NOTICE OF PUBLICATION
10/23/2002
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/26/2002
CNEA
EXAMINERS AMENDMENT MAILED
08/14/2002
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/06/2002
CNRT
NON-FINAL ACTION MAILED
04/30/2002
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/26/2002
CNRT
NON-FINAL ACTION MAILED
08/27/2001
DOCK
ASSIGNED TO EXAMINER
08/16/2001
DOCK
ASSIGNED TO EXAMINER
08/10/2001
Continuous trademark protection
Get notified about every new filing that threatens GEISINGER CANCER INSTITUTE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.